PDRN Skincare Project Planning
A planning guide for brands, product managers and regulatory teams preparing a PDRN cosmetic brief: material identity, concentration basis, formats, evidence and claim limits.
Project planning guide
PDRN is a name, not a specification
The name PDRN is not a complete raw-material specification and should not be treated as one.
Materials sold under the PDRN name can differ in origin, composition, carrier, active content and documentation, and their status can differ between markets. A workable brief has to name the supplied material, the supplier, the label name or INCI, the origin, the carrier, the concentration basis, the supporting documents and the destination market. Until those are fixed, a headline percentage does not mean anything a formulator or a regulator can rely on.
This page sets out the decisions to settle before sampling, so the first formula is built on a documented material and a claim route that fits a cosmetic product.
When a PDRN project is ready, and when it is not
Readiness depends less on the ingredient and more on whether the brand can document the material and keep the positioning cosmetic.
Use it when
- The brand can define the intended cosmetic positioning without relying on treatment or regeneration claims.
- The supplier material and concentration basis can be documented.
- The destination market is known before the formula and artwork are locked.
- The project budget includes formula, package, microbiological and claim-evidence decisions appropriate to the finished product.
Reconsider it when
- The project depends on injectable, wound-healing, cell-regeneration or disease-treatment associations.
- The raw-material source, origin or label name cannot be documented.
- A headline percentage is being requested without stating whether it refers to pure or active content or an as-supplied solution.
- Vegan, animal-origin-free or traceability claims cannot be reconciled with supplier documents.
Dosage-form directions to evaluate
Each format raises a different formulation or packaging question. These are development directions, not existing stock formulas that already contain PDRN.
Water-based serum or essence
The main questions are the water phase, preservation and how the material behaves across the intended pH and viscosity range.
Emulsion or cream
Check compatibility with the emulsifier system, oil phase and processing temperature, and how the material is added during manufacture.
Eye-area cosmetic
Eye-area use adds safety expectations and tighter claim wording. Both need to be scoped before the formula is fixed.
Mask or professional-use format
Substrate and serum compatibility, fill per sachet and the professional channel's documentation expectations all need confirming.
Freeze-dried or two-part format
Only where stability work shows a reason for it. The dry format adds components, specifications and testing, so it needs a technical case.
No current catalogue product is presented here as a PDRN formula. Format feasibility is confirmed per project against the selected material.
Raw-material identity checklist
Collect these before quoting a concentration. They decide what can be written on the label, which markets are open and which claims have any support.
- Supplier and exact commercial material.
- Proposed label or INCI name, with supplier documentation.
- Biological or synthetic origin where relevant.
- Carrier or solvent, and total solids or active basis.
- Batch COA and specification.
- Storage and handling conditions.
- Market-specific status, to be reviewed for each destination.
- Claim support supplied with the material, kept separate from evidence on the finished product.
Supplier data on the raw material describes the material. It is not evidence about your finished product, which has its own formula, level, pack and use conditions.
How a PDRN brief moves to sampling
The order matters: documentation and market come before percentage and artwork.
Step 1: Select and document the material
Confirm the supplier, commercial grade, label name, origin and carrier, and collect the COA and specification.
Step 2: Confirm the destination market
Review the material's status for each market before the formula is locked, since status can differ between regions.
Step 3: State the concentration basis
Agree whether the level refers to active content, solids or the as-supplied material, and use the same basis on every document.
Step 4: Choose the dosage form and pack
Pick the format and the final pack together, since compatibility and preservation depend on both.
Step 5: Fix claim wording and evidence route
Draft the cosmetic claims, list the prohibited wording and decide which claims need finished-product evidence.
Step 6: Sample, test and check artwork
Sample against the brief, run the agreed test scope and check artwork and INCI against the formula before release.
Testing and evidence matrix
Scope is agreed per formula, pack, claim and market. Listing an area here does not imply a result.
| Area | Scope to agree |
|---|---|
| Formula identity and raw-material basis | Confirm the agreed material and concentration basis are what the formula actually contains. |
| Physical and chemical stability | Appearance, pH, viscosity and other relevant properties over the agreed stability programme. |
| Preservation and PET or challenge testing | For water-containing products, agree the preservative strategy and the challenge-test scope. |
| Pack compatibility | Test with the final pump, dropper, jar, mask sachet or two-part pack. |
| Safety and claim substantiation | Matched to the actual claim and market, not to the ingredient name. |
| Third-party report scope | Where the market, retailer or customer requires it, agree the laboratory and report scope in advance. |
| Artwork and INCI consistency | Check label name, ingredient list and claims against the final formula before release. |
No fixed PDRN level, absorption figure or performance result is published here, because none holds across different materials and formulas.
Claim boundaries for a PDRN cosmetic
Claim wording decides how a product is regulated. The same ingredient can sit in a cosmetic or fall outside one depending on what the pack says.
Possible cosmetic direction
- Appearance of skin
- Moisturising
- Conditioning
- Comfort
Needs finished-product evidence
- Visible fine lines
- Firmness
- Radiance
- Consumer-perception results
- Instrument-based performance
Regulatory red flags
- Healing or regeneration
- Treatment of inflammation or disease
- Post-injection equivalence
- Structural or physiological claims
Cosmetic directions are usable only after the final wording and evidence route are agreed. The FDA page below is a US example; each destination market still requires its own review.
What to include in a PDRN brief
If some fields are still open, say so. Knowing what is undecided is more useful than a placeholder percentage.
- Destination country and sales channel.
- Supplier material and documents already selected, if any.
- Proposed INCI or label name and origin expectations.
- Concentration, and whether it is on an active, solids or as-supplied basis.
- Dosage form, texture and pack reference.
- Cosmetic claims you want, and wording you must avoid.
- Quantity, launch date and expected test and document set.
Related pages
Formula, documentation and packaging work combined in one project.
The wider technology page and the other planning guides.
What sits in routine manufacturing and what is scoped separately.
Current skincare formats and packaging directions.
What to settle before briefing a serum manufacturer.
Send the brief when the fields below are ready.
Official references
Starting points for your own regulatory review. They do not approve any ingredient or product.
US example of how claim wording can move a product from cosmetic toward drug status. Other destination markets need their own review.
Starting point for ingredient names and EU regulatory research. A CosIng entry does not show that a finished product is compliant.
Questions buyers ask
Can you quote a PDRN percentage before the material is chosen?
Not meaningfully. The same percentage can describe very different amounts depending on whether it refers to active content, solids or an as-supplied solution, and materials differ in composition. The basis is fixed with the material, and the percentage follows.
Does a supplier's data sheet support claims on my product?
It supports statements about the raw material. Claims on the finished product depend on your formula, level, pack and use, so they need their own evidence route matched to the wording and market.
Is PDRN permitted in every market?
That cannot be assumed. Status depends on the specific material, its origin and name, and each destination market's rules. Review it per market before the formula and artwork are locked.
Can a vegan or animal-origin-free claim be made?
Only if the supplier documents support it for the exact material used. If origin documentation and the claim do not line up, the claim should be dropped or the material changed.
Define a PDRN skincare brief before sampling
Send the material you are considering, the destination market, the format and the claims you have in mind. We will come back with the open identity, testing and claim questions before any sample is made.
Pricing and timing depend on the formula, packaging, quantity, testing and destination market.